Clinical Trials Logo

Chronic Thrombocytopenic Purpura clinical trials

View clinical trials related to Chronic Thrombocytopenic Purpura.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT01462916 Terminated - Clinical trials for Chronic Thrombocytopenic Purpura

Honey in Chronic Immune Thrombocytopenia

Start date: October 2014
Phase: N/A
Study type: Observational

Based on the assumption that honey may have an immunomodulatory effect, the aim of our present study will be to verify whether the intake of honey, as a natural substance, in patients with chronic Immune Thrombocytopenia (ITP) could affect the platelet number and hence could affect the bleeding severity. Thirty patients suffering from chronic ITP will be recruited from the Hematology Clinic of the Pediatric Hospital of Ain Shams University, Cairo, Egypt. The diagnosis of ITP will be based on the presence of isolated thrombocytopenia with a peripheral blood platelet count less than 100 x 109/L, and absence of any obvious initiating and/or underlying cause of the thrombocytopenia. Chronic ITP is defined as ITP for at least 12 months. The age of the patients will range from 5 to 15 years, and they will be of both sexes. This study was approved by the local Ethics Committee of the Pediatric Department of Ain Shams University, and an informed consent to participate in this study will be obtained from at least one parent of each patient. Furthermore, an ascent form will be obtained from each patient above 7 years of age.